[go: up one dir, main page]

BR9910401A - New formulation containing paroxetine - Google Patents

New formulation containing paroxetine

Info

Publication number
BR9910401A
BR9910401A BR9910401-6A BR9910401A BR9910401A BR 9910401 A BR9910401 A BR 9910401A BR 9910401 A BR9910401 A BR 9910401A BR 9910401 A BR9910401 A BR 9910401A
Authority
BR
Brazil
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
BR9910401-6A
Other languages
Portuguese (pt)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9910401A publication Critical patent/BR9910401A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"NOVA FORMULAçãO CONTENDO PAROXETINA" Hidrocloreto de paroxetina, em uma forma outra que o hemihidrato, que é formulado na forma de cápsulas sob condições tais que não existe conversão detectável para o hemihidrato durante o processo de tabletagem."NEW FORMULATION CONTAINING PAROXETINE" Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated in the form of capsules under conditions such that there is no detectable conversion to the hemihydrate during the tableting process.

BR9910401-6A 1998-05-13 1999-05-13 New formulation containing paroxetine BR9910401A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BR9910401A true BR9910401A (en) 2001-01-09

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910401-6A BR9910401A (en) 1998-05-13 1999-05-13 New formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
SK95099A3 (en) * 1997-01-15 2000-01-18 Smithkline Beecham Plc Process for the preparation of free-flowing form of paroxetine hydrochloride, pharmaceutical composition containing same and use thereof
IL136831A0 (en) * 1997-12-19 2001-06-14 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets

Also Published As

Publication number Publication date
TR200003350T2 (en) 2001-03-21
BG105010A (en) 2001-07-31
AP2000002019A0 (en) 2000-12-31
NO20005683L (en) 2000-12-05
CN1308521A (en) 2001-08-15
NO20005683D0 (en) 2000-11-10
GB9810181D0 (en) 1998-07-08
WO1999058113A2 (en) 1999-11-18
JP2002514591A (en) 2002-05-21
IL139594A0 (en) 2002-02-10
CA2331871A1 (en) 1999-11-18
WO1999058113A3 (en) 2000-02-17
AU3940999A (en) 1999-11-29
SK17142000A3 (en) 2001-06-11
EP1077682A2 (en) 2001-02-28
EA200001174A1 (en) 2001-06-25
ID28019A (en) 2001-05-03
KR20010043574A (en) 2001-05-25
HUP0102064A2 (en) 2002-05-29
PL344573A1 (en) 2001-11-05
ZA200006562B (en) 2002-02-13

Similar Documents

Publication Publication Date Title
DK0941218T3 (en) Antithrombotic organic nitrates
ES2059408T3 (en) A PROCESS FOR THE PREPARATION OF A COMPOUND.
ES2043625T3 (en) ARILOXICARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE.
FI962445A7 (en) Paroxetine tablets and method for their preparation
YU56995A (en) ONLY DERIVED INDOLA
ID27652A (en) AMIDA DEMONSTRATIONS USED AS A SITOKINA PRODUCTION INHIBITOR
GT199900040A (en) BICYCLE [2.2.1] HEPTANS AND RELATED COMPOUNDS.
BR9911771A (en) Substituted cyclic compounds, a process for their preparation and pharmaceutical compositions containing the same
BR9811099A (en) Urokinase inhibitors
FI963510L (en) Isoxazoline compounds as inhibitors of TNF release
BR9810163A (en) Compounds or their compositions
BR9611263A (en) Cleaning pad for toilet.
ES2062239T3 (en) DIAMIDES OF PIRIMIDIN-4,6-DICARBOXILIC ACIDS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME, AS WELL AS MEDICINES BASED ON THESE COMPOUNDS.
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
DK1086097T3 (en) Sulfonylbenzene compounds as anti-inflammatory / analgesic agents
MX9405434A (en) HYDROGEN PEROXIDE COMPOSITION.
BR9910445A (en) Pharmaceutical preparation
ES2043863T3 (en) PROCEDURE FOR PREPARING 1,2,5,6-TETRAHYDROPYRIDINE DERIVATIVES.
BR0014461A (en) Compound and method for preparing the same
FI955498A0 (en) Nipecotinic acid derivatives as anticoagulants
BR9910402A (en) New formulation containing paroxetine
NO972887D0 (en) Piperidinedacetic acid derivatives useful as fibrinogen antagonist agent
BR9910401A (en) New formulation containing paroxetine
BR9812780A (en) 2-aryl-3-aroilbenzo [b] thiophenes useful for the treatment of estrogen loss syndrome
FR2586029B1 (en) CORROSION INHIBITOR COMPOSITIONS

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]